Indication
Submental fat
10 clinical trials
10 products
Product
RZL-012Clinical trial
An Open Label Phase 2 Study to Evaluate the Effects of a Local Anesthetic, Anti-inflammatory Medications and Compression Garments on RZL-012-Induced Adverse EventsStatus: Completed, Estimated PCD: 2023-06-12
Product
RZL-012+MedrolProduct
RZL-012+Celecoxib+ZyrtecClinical trial
An Open Label Phase 2 Study to Compare the Pharmacokinetics, Efficacy and Safety of RZL-012 in Chinese Subjects Seeking Submental Fat Reduction vs. Non-Chinese Subjects Seeking Submental Fat ReductionStatus: Completed, Estimated PCD: 2023-05-30
Clinical trial
A Randomized, Double-blind, Multi-center, Placebo-controlled, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental FatStatus: Completed, Estimated PCD: 2020-07-02
Product
DWJ211Product
Normal salineProduct
10XB-101Clinical trial
A Multi-Center, Randomized, Double-Blinded, Vehicle-Controlled Study of the Safety and Efficacy of 10XB-101 in Adult Subjects With Submental FatStatus: Active (not recruiting), Estimated PCD: 2024-05-01
Clinical trial
A Multi-Center, Open Label, Single Ascending Dose Safety and Tolerability Study of Subcutaneously Administered 10XB-101 in Adult Subjects With Excessive Submental FatStatus: Completed, Estimated PCD: 2022-06-30
Product
RZL-012+LidacaineProduct
Polyene PhosphatidylcholineClinical trial
A Randomized, Double-blind, Placebo-controlled, Single Center and Single Dose Phase Ⅰ Study to Evaluate Pharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of AYP-101 S.C. Injection in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-08-16
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multi-center, Phase III Study to Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental FatStatus: Completed, Estimated PCD: 2023-02-18
Product
PlaceboProduct
MT921Clinical trial
A Single Blind, Randomized, Placebo-controlled, Phase 2a, 2-cohort Study for the Evaluation of Safety and Efficacy of RZL-012 for Submental Fat Reduction in Healthy Volunteers.Status: Completed, Estimated PCD: 2020-09-16
Clinical trial
A Double Blind, Randomized, Three Arm, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of RZL-012 in Subjects Seeking for Submental Fat ReductionStatus: Completed, Estimated PCD: 2022-04-20
Clinical trial
An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of a Second Treatment Session of RZL-012 Into Submental Fat in Subjects Seeking Further ImprovementStatus: Completed, Estimated PCD: 2023-07-30